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The generation of induced pluripotent stem cells (iPSCs) is considered to be stochastic with aminute fraction
of cells becoming pluripotent. Recently in Cell, Buganim et al. (2012) changed this view using single cell
analyses to reveal a stochastic early and hierarchical late phase, with implications for productive alternative
reprogramming strategies.The dramatic reprogramming of a somatic
cell into a pluripotent one equivalent in
terms of developmental potentials to
those only found in early embryo such as
a blastocyst is a tremendous achieve-
ment. Although three approaches are
known to accomplish this feat, somatic
cell nuclear transfer (SCNT) (Gurdon
et al., 1958), cell fusion, and transcription
factor (TF)-based reprogramming, the
generation of induced pluripotent stem
cells (iPSCs) by four TFs represents
a breakthrough that has enriched our
understanding of cell fate decisions in
a fundamental way (Takahashi and Yama-
naka, 2006). Despite intense interest in
this topic, how TF-based reprogramming
actually occurs remains unclear at this
time, due in part to the low efficiency of
iPSCs generation. Experimental evidence
and mathematic modeling suggest that
reprogramming to iPSCs is a stochastic
process (Hanna et al., 2009; Yamanaka,
2009), in contrast to reprogramming by
SCNT, which is mostly considered to be
deterministic (Figure 1A). In a recent issue
of Cell, Buganim et al. (2012) addressed
this issue using single cell analysis of
reprogramming by Yamanaka factors,
which indicates a two-stage process
that is stochastic at the early phase fol-
lowed by a more deterministic or hierar-
chical late phase governed by specific
regulatory factors (Buganim et al., 2012).
Remarkably, these analyses allowed
them to replace the original Yamanaka
factors with downstream factors identi-
fied in the late phase. The new findings,
along with the single cell approach, may
change the way we view reprogramming.The Yamanaka factors, Oct4, Sox2,
Klf4, and Myc (OSKM), previously known
for their role in development and cancer,
were discovered in 2006 for their com-
bined ability to reprogram mouse embry-
onic fibroblast (MEF) cells to iPSCs
(Takahashi and Yamanaka, 2006). Earlier
attempts to understand how the Yama-
naka factors work focused on popu-
lation-based global analyses such as
microarrays, proteomics and functional
genomics/epigenetics that have gener-
ated large data sets documenting the
molecular changes triggered by the
Yamanaka factors. One such data set
suggested that reprogramming goes
through three distinct phases: initiation,
maturation, and stabilization (Sama-
varchi-Tehrani et al., 2010), consistent
with the sequential activation of various
known stem cell markers and epigenetic
changes (Mikkelsen et al., 2008). At the
cellular level, the first morphological
change upon the transduction of the
Yamanaka factor is the acquisition of
epithelial properties by MEFs, suggesting
that a mesenchymal-to-epithelial transi-
tion (MET) initiates the reprogramming
process (Li et al., 2010), a conclusion
corroborated by functional genomics
(Samavarchi-Tehrani et al., 2010).
Detailed analysis of the MET process re-
vealed a clear division of labor among
the Yamanaka factors at the transcrip-
tional level, i.e., the suppression of
mesenchymal genes such as Snail,
TGF-b and TGF-b receptor 2 by Sox2,
Oct4, and c-Myc, followed by the
induction of epithelial genes including
E-cadherin by Klf4 (Li et al., 2010). DespiteCell Stem Cell 1these early insights on the role of the
Yamanaka factors in reprogramming,
population-based investigations might
have missed minor yet critical regulators
due to the inherent low signal-to-noise
ratio because only a tiny fraction of cells
eventually become iPSCs.
In order for a somatic cell to eventually
give rise to iPSCs, one can imagine that
the forced expression of the Yamanaka
factors would need to bind to accessible
genomic sites and start to activate the
expression of those targets; then this first
wave of genes, termed first responders,
in turn would not only activate further
downstream regulators but also open up
the chromatin domains previously not
accessible in MEFs for transcription
activations (Pei, 2009); finally, the first
responders along with their targets would
then be able to activate the core pluripo-
tency circuitry, turn off somatic genes,
and even silence the exogenous reprog-
ramming factors, effectively rewriting
the cell fate code from a somatic into
a pluripotent one (Pei, 2009). Because
reprogramming is a lengthy process, the
original cell keeps on dividing and only
a small fraction of its progeny contributes
to an iPSC colony. The rest of the cells
would have aborted the reprogramming
process and assumed cell fates that
are short of full pluripotency, e.g., partially
reprogrammed cells. Thus, the ideal
approach to track the molecular events
essential to successful reprogramming
is to analyze individual cells during
reprogramming.
The Jaenisch group deployed the
latest technology for single cell analysis1, October 5, 2012 ª2012 Elsevier Inc. 445
Figure 1. Schematic View of Reprogramming Models and Phases
(A) Twomodels exist to explain the reprogramming of somatic cells to pluripotent ones. SCNT is thought to reprogram by a deterministic mechanism (top). SCNT
is known to be fast. The generation of iPSCs is thought to be stochastic (bottom). The process is lengthy and inefficient. A combined model may have both
stochastic and deterministic phases (the sliding slope).
(B) The likely cellular events of reprogramming as revealed by single cell analysis.
Cell Stem Cell
Previewsto reexamine the molecular events asso-
ciated with the mechanism of action
for the Yamanaka factors. Using arrays,
they analyzed the expression of 48 genes
including those for ESC chromatin re-
modeling, cell cycle regulation, signal
transduction, and pluripotent markers in
single cells sorted from different stages
of OSKM-induced reprogramming re-
presenting early, intermediate, and fully
reprogrammed iPSCs (Buganim et al.,
2012). They showed that at the very early
stage of reprogramming, the expression
of these genes exhibited large variations
between different individual cells as
predicted by the stochastic model. An
individual cell with each activation profile
was then clonally expanded, and the
resulting sister cells were dynamically
traced individually for the expression of
the same set of 48 genes at different
stages during further reprogramming.
This single-cell tracing system provided
a comprehensive view of the molecular
events over time and in terms of differen-
tiation potential from MEFs to iPSCs. As
a result, they made several key observa-
tions on the reprogramming process.446 Cell Stem Cell 11, October 5, 2012 ª201They observed that the cell cycle regu-
lators and MET markers are detected at
the early stage in both iPSC-producing
and non-iPSC-producing cells. This is
consistent with earlier work on cell cycle
and MET (Mikkelsen et al., 2008) (Li
et al., 2010). Then, they found a surprise:
the early activation of Oct4, the most
critical gene for pluripotency as its
expression is essential to maintain plurip-
otency for the inner cell mass of mouse
blastocysts in vivo and mouse ESCs
in vitro, is not predictive for the genera-
tion of full iPSCs. In contrast, cells
expressing a particular set of genes
heterogeneously at the early phase pro-
gressed into a full pluripotent state later.
This set of ‘‘iPSC predictive’’ genes,
Esrrb, Utf1, Lin28, and Dppa2, appear to
be more informative in forecasting the
reprogramming outcome. Remarkably,
single cell profiling at the later stage of
reprogramming identified Sox2 as a reli-
able mark for those cells that eventually
progress into iPSCs. Sox2 is a well-known
partner for Oct4 and has been in its
shadow in previous literature on stem
cell pluripotency because it can be sub-2 Elsevier Inc.stituted functionally by a small molecule
during reprogramming. Yet, single cell
analysis revealed that the activation of
endogenous Sox2 sets a hierarchical
course of action leading to the eventual
acquisition of pluripotency, suggesting
that the post-Sox2 events are no longer
stochastic. One might argue that reprog-
ramming becomes deterministic after
the activation of Sox2 at the single cell
level (Figure 1B).
The story did not end at Sox2. Buganim
et al. (2012) took advantage of the predic-
tive power of their model and proposed
a bold move: to replace the Yamanaka
factors with their downstream factors.
This is brilliant because the outcome not
only validates their model but also opens
up a new direction. To this end, they found
that as a group, Lin28, Sall4, Esrrb, and
Dppa2 were able to reprogram MEFs to
iPSCs. Although these four factors have
been shown previously to be able to
enhance reprogramming, it is remarkable
that they are sufficient by themselves
without the original Yamanaka factors
and Nanog (Figure 1). Although the
efficiency remains very low for this new
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by optimizing the reprogramming envi-
ronment as has been achieved with the
Yamanaka factors in the near future
(Chen et al., 2011).
The realization that reprogramming by
defined factors is a stochastic early and
deterministic late processmay encourage
further efforts to manipulate the ratio
between stochastic and deterministic
phases (Figure 1A). Because reprogram-
ming is a collaboration between the
defined factors and the culture environ-
ment (Li et al., 2010), one may speculate
that ultimately, a ‘‘perfect’’ reprogram-
ming environment may allow reprogram-
ming to proceed with no or very short
stochastic phase (Figure 1A). If so, it
may be feasible to achieve all determin-istic reprogramming with defined factors,
thus, narrowing or reconciling the
difference between SCNT and iPSC
(Figure 1A). As pointed out by the authors,
single cell analysis is at its infancy. Yet,
it has already helped the reprogramming
field so nicely. Much should be antici-
pated from this line of inquiry.
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Ito et al. (2012) recently report inNatureMedicine that fatty acid oxidation (FAO) regulated by PPARd controls
asymmetric division in hematopoietic stem cells (HSCs). This metabolic mechanism prevents HSC exhaus-
tion and is downstream of the promyelocytic leukemia protein PML, suggesting therapeutic implications for
HSC function and disease.Hematopoietic stem cells (HSCs) are
some of the most mysterious entities
of an organism, subdivided into an
incredible variety of subsets. HSCs are
exquisitely sensitive to changes in
transcriptional networks and external
informatory molecules, such as those
provided by the niche microenvironment.
The metabolism of these essentially
quiescent cells has been the focus of
many recent studies (reviewed in Suda
et al., 2011) but the contribution of
lipid metabolism remains unexplored
(Suda et al., 2011). Ito et al. now reportfindings that not only bridge nuclear
organization, transcriptional control, and
lipid metabolism in decisions underlying
asymmetric cell division, but that also
have major implications for therapeutic
manipulation of HSCs.
In a previous study, the Pandolfi group
reported that deletion of pml leads to
loss of HSC quiescence, resulting in
their transient amplification and sub-
sequent exhaustion (Ito et al., 2008).
Here, the authors demonstrate that PML
activates PPARd, a nuclear receptor that
has a key role in stem cell maintenance.Indeed, in multiple in vivo or ex vivo
assays, conditional loss of ppard was
found to decrease HSC abundance and
repopulating ability while treatment with
specific agonists improved HSC function.
Loss of self-renewal likely results from
an increase in HSC cycling, so that loss
of either pml or ppard results in the
accumulation of committed progenitors.
Conversely, defects in pml/ HSCs
were partly rescued by PPARd agonists.
PPARs are central regulators of metabo-
lism and control mitochondrial function,
in particular fatty acid oxidation (FAO).1, October 5, 2012 ª2012 Elsevier Inc. 447
